Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC for cell therapy of type 1 diabetes
Abstract
Publication Date:
2019
Short description:
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC for cell therapy of type 1 diabetes / Chimienti, R., Baccega, T., Manenti, F., Torchio, S., Pellegrini, S., Pritchard-Meaker, T., Sordi, V., Lombardo, A., Malnati, M., Piemonti, L.. - In: DIABETOLOGIA. - ISSN 0012-186X. - 62:(2019), pp. 198-198. (55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) Barcelona, SPAIN SEP 16-20, 2019).
Iris type:
4.2 Abstract in Atti di convegno
List of contributors:
Chimienti, R; Baccega, T; Manenti, F; Torchio, S; Pellegrini, S; Pritchard-Meaker, T; Sordi, V; Lombardo, A; Malnati, M; Piemonti, L
Book title:
DIABETOLOGIA
Published in: